Literature DB >> 9448854

A highly sensitive method for large-scale measurements of 1,25-dihydroxyvitamin D.

N C Arbour1, T K Ross, C Zierold, J M Prahl, H F DeLuca.   

Abstract

A quantitative method for measuring 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3) was developed utilizing a luciferase reporter gene under the control of the highly inducible 25-hydroxyvitamin D3 24-hydroxylase promoter in a stably transfected cell line. Transient transfections with constructs containing the 24-hydroxylase gene promoter 5' to a luciferase reporter were first performed in cell lines with high levels of vitamin D receptor, i.e., the rat osteosarcoma (ROS 17/2.8) and human breast cancer (T-47D) cell lines. ROS 17/2.8 cells, stably transfected with the plasmid, gave a 60-fold stimulation with 10(-10) M 1,25-(OH)2D3. A standard curve was constructed showing a large range of response to 1,25-(OH)2D3 (1 pg to 1 ng). The assay was adapted to microtiter plates, which permits a large number of samples to be assayed simultaneously. Other metabolites of vitamin D and analogs such as 25-hydroxyvitamin D3, 24,25-dihydroxyvitamin D3, and 1 alpha-hydroxyvitamin D3 have negligible effects on the detection of 1,25-(OH)2D3, thus eliminating the need for purification of sample. The sensitivity of the method permitted the use of 100 microliters of serum with excellent results. Comparison of this method with a commercially available assay demonstrates that it gives higher sensitivity, simpler manipulations, and comparable results.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9448854     DOI: 10.1006/abio.1997.2439

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  7 in total

1.  RIPK1 binds to vitamin D receptor and decreases vitamin D-induced growth suppression.

Authors:  Waise Quarni; Panida Lungchukiet; Anfernee Tse; Pei Wang; Yuefeng Sun; Ravi Kasiappan; Jheng-Yu Wu; Xiaohong Zhang; Wenlong Bai
Journal:  J Steroid Biochem Mol Biol       Date:  2017-02-01       Impact factor: 4.292

2.  CYP2R1 is a major, but not exclusive, contributor to 25-hydroxyvitamin D production in vivo.

Authors:  Jinge G Zhu; Justin T Ochalek; Martin Kaufmann; Glenville Jones; Hector F Deluca
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-09       Impact factor: 11.205

3.  Nucleo-cytoplasmic cycling of the vitamin D receptor in the enterocyte-like cell line, Caco-2.

Authors:  Anna Klopot; Kenneth W Hance; Sara Peleg; Julia Barsony; James C Fleet
Journal:  J Cell Biochem       Date:  2007-02-15       Impact factor: 4.429

Review 4.  Ring-A-seco analogs of 1α,25-dihydroxy-19-norvitamin D3.

Authors:  Agnieszka Glebocka; Rafal R Sicinski; Lori A Plum; Hector F Deluca
Journal:  J Steroid Biochem Mol Biol       Date:  2012-10-09       Impact factor: 4.292

5.  A novel SNP in a vitamin D response element of the CYP24A1 promoter reduces protein binding, transactivation, and gene expression.

Authors:  Alanna Roff; Robin Taylor Wilson
Journal:  J Steroid Biochem Mol Biol       Date:  2008-09-06       Impact factor: 4.292

6.  Biologically active noncalcemic analogs of 1alpha,25-dihydroxyvitamin D with an abbreviated side chain containing no hydroxyl.

Authors:  Lori A Plum; Jean M Prahl; Xiaohong Ma; Rafal R Sicinski; Sumithra Gowlugari; Margaret Clagett-Dame; Hector F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-26       Impact factor: 11.205

7.  Pharmacokinetics of a New Oral Vitamin D Receptor Activator (2-Methylene-19-Nor-(20S)-1α,25-Dihydroxyvitamin D3) in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism on Hemodialysis.

Authors:  Richa Pandey; Julia B Zella; Jinge G Zhu; Lori A Plum; Margaret Clagett-Dame; William J Blaser; Wendy Bedale; Hector F DeLuca; Daniel W Coyne
Journal:  Drugs R D       Date:  2017-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.